|Mr. Bruce S. Rosenbloom||CFO & Treasurer||473.47k||N/A||1969|
|Mr. Matthew N. Hulett||CEO, Pres & Director||N/A||N/A||1971|
|Mr. Mark Moseley||Chief Technology & Information Officer||N/A||N/A||N/A|
|Mr. Daniel Job Pingree||Chief Marketing Officer||N/A||N/A||N/A|
|Ms. Jacqueline Smith||VP of People||N/A||N/A||N/A|
|Wendy Zalai||Corp. Controller & Corp. Sec.||N/A||N/A||N/A|
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
PetMed Express, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 1. The pillar scores are Audit: 6; Board: 2; Shareholder Rights: 1; Compensation: 3.